Investors

OvaScience is a global fertility company dedicated to improving treatment options for women around the world.

OVAS (Common Stock)
Price & Exchange
$1.38
NASDAQ
Change (%)
 Stock is Up 0.03 (2.22%)
Volume
1,290,235
12/14/17      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

Investor Overview

Recent News

More »
DateTitle 
11/02/17OvaScience Reports Third Quarter 2017 Financial Results
– Initial Safety Data from First 20 Patients in OvaPrime℠ Clinical Trial Expected by Year-End – – Granted Exclusive License to IVF Japan Group to Offer the AUGMENT℠ Treatment in Japan – – Conference Call Today at 4:30 p.m. ET – WALTHAM, Mass.--(BUSINESS WIRE)--Nov. 2, 2017-- OvaScience℠ (NASDAQ:OVAS), a fertility company focused on the discovery, development and commercialization of new treatment options for women, today... 
Printer Friendly Version
10/26/17OvaScience to Host Third Quarter 2017 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--Oct. 26, 2017-- OvaScienceSM (NASDAQ: OVAS), a fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. ET on Thursday, November 2, 2017 to discuss third quarter 2017 financial results and provide a general corporate update. The conference call may be accessed by dialing +1-888-424-8151 for U.S. c... 
Printer Friendly Version
08/03/17OvaScience Reports Second Quarter 2017 Financial Results
– Fertilization of Bovine EggPC Cell-Derived Egg in OvaTure Program on Track for Year-End – – Completed Target Enrollment in OvaPrime Clinical Safety Study; Expect to Announce Initial Safety Data in First 20 Patients by Year-End – – Sufficiently Funded to Support Operations into 1Q 2020, Enabling Key Milestones – – Conference Call Today at 4:30 p.m. ET – WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 3, 2017-- OvaScienceS... 
Printer Friendly Version
07/27/17OvaScience to Host Second Quarter 2017 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--Jul. 27, 2017-- OvaScienceSM (NASDAQ: OVAS), a fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. ET on Thursday, August 3, 2017 to discuss second quarter 2017 financial results and provide a general corporate update. The conference call may be accessed by dialing +1-888-424-8151 for U.S. ca... 
Printer Friendly Version

Upcoming Events

More »
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources